Dementia
Wearable ultrasound device reduces amyloid, boosts cognition in Alzheimer’s mouse models.
AI model analyzes brain scans to detect Alzheimer’s stage with 99% accuracy—potentially enabling faster, earlier ...
Behavioral therapy matches drug treatment in easing overactive bladder symptoms in Parkinson’s without added side effects.
Ambroxol was safe in Parkinson disease dementia but showed no cognitive benefit, study finds.
Ambroxol was safe in Parkinson’s dementia but showed no clear cognitive benefit.
Excess brain iron in Down syndrome linked to oxidative damage and early-onset Alzheimer’s, new study finds.
α-synuclein PET tracers may transform Parkinson’s diagnosis, tracking, and trials, says Merck’s Robert Drolet, PhD.
The new blood test is less invasive and more accessible to patients.
Parkinson's disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
Dr. Anne Marie Morse discusses the troubling connection between sleep disorders and dementia.
The caps on the end of chromosomes are called telomeres.
A new model called the Florey Dementia Index (FDI) can accurately predict the age at onset of MCI and AD.
The research group will design a vaccine that won't promote inflammation.
The phase 2 randomized trial included patients with amyloid-confirmed mild cognitive impairment or early Alzheimer disease.
Researchers assessed the molecular underpinnings that may increase the risk of Alzheimer’s disease following TBI.
Researchers have developed a novel therapy that selectively removes aggregated tau proteins, which are associated with AD.
Dr. Alva discusses a study that evaluated the safety of pimavanserin in frail elderly patients with NDD.
Hormone therapy was associated with a 19% lower relative risk in Black women aged 65 to 74 years.
A 5-minute assessment was found to improve the diagnosis of mild cognitive impairment and dementia.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.